Pharmacogenomic testing can be an effective tool to enhance medication safety and
efficacy. Pharmacogenomically actionable medications are widely used, and approximately …

Since September 2010, more than 10,000 patients have undergone preemptive, panel‐
based pharmacogenomic testing through the Vanderbilt Pharmacogenomic Resource for …

Although the field of pharmacogenetics has existed for decades, practioners have been slow
to implement pharmacogenetic testing in clinical care. Numerous publications describe the …

While recent discoveries have paved the way for the use of genotype-guided prescribing in
some clinical environments, significant debate persists among clinicians and researchers …

Genetic modulation of drug response can cause serious, potentially life-threatening adverse
drug reactions, can increase susceptibility to drug–drug interactions and can diminish or …

The implementation of pharmacogenomics (PGx) has come a long way since the dawn of
utilizing pharmacogenomic data in clinical patient care. However, the potential benefits of …

Routine integration of genotype data into drug decision making could improve patient safety,
particularly if many relevant genetic variants can be assayed simultaneously before …

Pharmacogenomics has identified important drug–gene interactions that affect the safety
and efficacy of medications. Direct-to-consumer genetic testing, when first introduced …

Purpose Preemptive pharmacogenetic testing aims to optimize medication use by having
genetic information at the point of prescribing. Payers' decisions influence implementation of …

Pre-emptive pharmacogenomic (PGx) testing of a panel of genes may be easier to
implement and more cost-effective than reactive pharmacogenomic testing if a sufficient …